Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board

News
- 24/04/2019

Helsinki, Finland: 24 April 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalized, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD), today announces that Professor Paul Fitzgerald MD, PhD, has joined the Company’s Scientific Advisory Board.

Paul Fitzgerald is Professor of Psychiatry and Director of the Epworth Centre for Innovation in Mental Health in Melbourne, Australia. He is also Director of Therapeutic Brain Stimulation at the Monash Alfred Psychiatry Research Centre (MAPrc).

More info on Nexstim’s website.